The state’s desired savings and efficiencies can be realized, but will likely take some effort.
Finding solutions to deliver better outcomes for patients.
Study shows that PBMs may lead to higher drug prices.
Experts offer their thoughts on what the specialty pharmacy industry will look like over the next year.
OptumRx will expand its drug discounts to employer-sponsored health plans starting next year. Here’s what the move means for healthcare.
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
A new HHS proposal could do away with—or at least forever change—PBM drug rebates. Here’s what that could mean for health execs.
Here’s five things to take away from Anthem’s launch of PBM IngenioRx.
Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
This comprehensive, pay-for-performance approach drives clinical quality and affordability.